NYSE
$0.4715▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $11.9MShares out 25.2M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
16- 8.26After-hours26.08.27 05:308-KKey event#●●●
Endovia Health Sciences, Inc.
Endovia Health Sciences entered into employment agreements on August 20, 2026, appointing Brady Cobb as Interim CEO and Michael Bondurant as Interim COO. The executives will receive annual base salaries of $300,000 and $275,000, respectively, along with performance-based cash bonuses tied to market capitalization milestones and stock option grants.…more
$0.4715+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.25Pre-market26.08.25 21:318-KKey event
Endovia Health Sciences, Inc.
Endovia Health Sciences has achieved its first regulatory milestone by securing FDA Investigational New Animal Drug (INAD) File No. 14145 for its canine oncology pain treatment, CannEpil, in collaboration with Lupvindol Biosciences. This milestone formally initiates the regulatory process, allowing the company to pursue development under the FDA's MUMS designation and conditional approval pathway.…more
$0.4715+0.00%vs prev closeView filingShare - 8.25Pre-market26.08.25 13:15filedEFFECTOther
Endovia Health Sciences, Inc.
The registration statement filed by Endovia Health Sciences, Inc. was declared effective by the SEC on August 24, 2026. This approval officially authorizes the company to proceed with the issuance and sale of securities as outlined in the filing.…more
$0.4715+0.00%vs prev closeView filingShare
15 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 8.31Pre-market26.08.31 21:30#●●●#●●●#●●●
Endovia Health Sciences Advances CannEpil® FDA Submission
Endovia Health Sciences plans to request an FDA pre-submission conference for its CannEpil® candidate, citing favorable shifts in federal cannabinoid policy. While the company is pursuing pipeline expansion and additional financing, it has yet to report verifiable commercial revenue milestones.…more
$0.4715+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 8.25Pre-market26.08.25 21:30
●●●●●●●● ●●●●● ●●●●●●
Endovia Health has established an Investigational New Animal Drug (INAD) file for its CannEpil veterinary program to treat cancer-related pain in dogs. While this marks a formal start to the FDA regulatory process, the company faces a long-term development path before potential commercialization.…more
$0.4715+0.00%vs prev close - 8.21Pre-market26.08.21 21:38
●●●●●●●● ●●●●● ●●●●●●
Splash Beverage Group is rebranding to Endovia Health Sciences and changing its stock ticker to EDVA. This move reflects the company's strategic shift from beverage operations to a diversified cannabinoid-based health sciences platform.…more
$0.4715+0.00%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report